United Financial Planning Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.3K Hold
92
﹤0.01% 358
2026
Q1
$5.58K Buy
+92
New +$5.36K ﹤0.01% 298

Other funds holding BMY

United Financial Planning Group's BMY Position: Q2 2026 in Review

United Financial Planning Group held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 92 shares worth $5.3K. The position accounts for ﹤0.01% of the portfolio, ranked #358.

United Financial Planning Group first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.58K in Q1 2026. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • United Financial Planning Group held 92 shares of Bristol-Myers Squibb worth $5.3K as of Q2 2026.
  • United Financial Planning Group left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of United Financial Planning Group's portfolio in Q2 2026, its #358 holding.
  • United Financial Planning Group first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
  • United Financial Planning Group's Bristol-Myers Squibb position peaked at $5.58K in Q1 2026.
  • 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on United Financial Planning Group's 13F filing for Q2 2026, filed 6 Aug 2026.